Infasurf 6 ml:

Each vial contains: Calfactant……… 6ml

Dosage Form: intratracheal Suspension (ready to use)

Indication:

Infasurf is indicated for prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS and for the treatment of premature infants who develop RDS. Infasurf decreases the incidence of RDS, mortality due to RDS, and air leaks associated with RDS.

Product Category: Infant Disease

Company: ONY Biotech Inc.